SCHEMBL5208001

SCHEMBL5208001

O=C(O)CC(NC(=O)c1ccc(CNCc2nc3ccccc3[nH]2)cc1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.58
ITGAV P06756 1/20 0.58
ALDH1A1 P00352 4/20 0.49
KMT2A Q03164 1/20 0.47
PIN1 Q13526 2/20 0.46
MAPT P10636 1/20 0.46
FPR1 P21462 2/20 0.45
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.45
APLNR P35414 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
CHRM1 P11229 1/20 0.43
ITGA2B P08514 1/20 0.43
PAK4 O96013 1/20 0.43
CDK2 P24941 1/20 0.43
TSHR P16473 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14025800 0.80 MAPT (0.66) ITGB3ITGAVALDH1A1KMT2AMAPT
SCHEMBL5878472 0.77 ITGB3 (0.89) ITGB3ITGAVALDH1A1
SCHEMBL12200972 0.75 GAA (0.65) ALDH1A1KMT2AGAACYP1A2CYP3A4
SCHEMBL5878233 0.74 ITGB3 (1.00) ITGB3ITGAVALDH1A1
SCHEMBL18782204 0.73 SLC40A1 (0.59) KMT2AMAPTGAAHTTTSHR
SCHEMBL22995641 0.72 MEN1 (0.61) ITGB3ITGAVKMT2AMAPTKDM4E
SCHEMBL3717471 0.72 MEN1 (0.61) ITGB3ITGAVKMT2AMAPTKDM4E
SCHEMBL5027698 0.72 MEN1 (0.61) ITGB3ITGAVKMT2AMAPTKDM4E
SCHEMBL14609161 0.72 PTPN1 (0.59) ITGB3ITGAVALDH1A1KMT2APIN1
SCHEMBL5202836 0.72 KDM4E (0.59) ITGB3KMT2AMAPTKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1135374-B9 BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS SCHERING CORP (US) 2007-02-21 EP disclosed
EP-1135374-B1 BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS SCHERING CORP (US) 2006-09-06 EP disclosed
EP-1135374-A1 BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2001-09-26 EP disclosed
US-6204282-B1 TREATING CANCER, RETINOPATHY, ATHEROSCLEROSIS, VASCULAR RESTENOSIS, OR OSTEOPOROSIS. SCHERING CORPORATION 2001-03-20 US disclosed
WO-2000032578-A1 BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2000-06-08 WO disclosed